Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase | Zendy

Michael V. Mazya | Zendy; J. Egido | Zendy; Gary A. Ford | Zendy; Kennedy R. Lees | Zendy; Robert Mikulík | Zendy; Danilo Toni | Zendy; Nils Wahlgren | Zendy; Niaz Ahmed | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Predicting the Risk of Symptomatic Intracerebral Hemorrhage in Ischemic Stroke Treated With Intravenous Alteplase

Author(s) -

Michael V. Mazya,

J. Egido,

Gary A. Ford,

Kennedy R. Lees,

Robert Mikulík,

Danilo Toni,

Nils Wahlgren,

Niaz Ahmed

Publication year - 2012

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.111.644815

Subject(s) - medicine , thrombolysis , stroke (engine) , framingham risk score , intracerebral hemorrhage , aspirin , logistic regression , clopidogrel , blood pressure , univariate analysis , cardiology , surgery , myocardial infarction , subarachnoid hemorrhage , multivariate analysis , engineering , mechanical engineering , disease

Symptomatic intracerebral hemorrhage (SICH) is a serious complication in patients with acute ischemic stroke treated with intravenous thrombolysis. We aimed to develop a clinical score that can easily be applied to predict the risk of SICH.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research